Get started
Author

Bilgin Demir

Observed names: B Demİr, B. Demir, Bilgin DEMİR, Demir, Bilgin
ORCID: 0000-0003-4380-9419
Observed ORCID: 0000-0003-4380-9419
OpenAlex ID: A5009130147
Treatment outcomes and prognostic factors in patients with driver mutant non-small cell lung cancer and de novo brain metastases
2024 · Seda Kahraman, Serdar Karakaya, et al. · Scientific Reports · 20
Atezolizumab combined with chemotherapy in the first-line treatment of extensive-stage small cell lung cancer: a real-life data of the Turkish Oncology Group
2022 · Mustafa Gürbüz, Yasin Kutlu, et al. · Journal of Cancer Research and Clinical Oncology · 13
Efficacy of gemcitabine plus nab-paclitaxel in second-line treatment of metastatic pancreatic cancer
2025 · Yasin Sezgin, Oğur Karhan, et al. · Scientific Reports · 9
PDF
Efficacy and safety of G-CSF prophylaxis in patients with extensive-stage small cell lung cancer receiving chemoimmunotherapy
2024 · Yusuf Ilhan, Gokhan Ucar, et al. · Expert Opinion on Pharmacotherapy · 8
HALP Score as a New Prognostic Factor for Patients with Metastatic Bladder Cancer
2023 · Omer Acar, Murat Ayhan, et al. · Journal of College of Physicians And Surgeons Pakistan · 8
PDF
Survival outcomes according to the tumor location and prognostic factor in metastatic rectal cancer: a multicenter retrospective cohort study
2024 · Olcun Umit Unal, Seval Akay, et al. · Frontiers in Oncology · 7
The Potential Prognostic Marker TyG Index Predicts Time to Brain Metastasis at HER2 Positive Breast Cancer
2023 · Ibrahim Karadag, Serdar Karakaya, et al. · Cancer Management and Research · 7
PDF
Systemic Immune Inflammation Index as a Key Marker of Survival and Immune-related Adverse Events in Immune Checkpoint Inhibitor Therapy
2022 · Ferhat Ekinci, Onur Yazdan Balcik, et al. · Journal of College of Physicians And Surgeons Pakistan · 7
PDF
KRAS mutation subtypes in metastatic non-small cell lung cancer
2025 · Ali Aytac, Bilgin Demir, et al. · American Journal of Cancer Research · 6
PDF
Prognostic Role of Pan Immune Inflammation Value and Systemic Inflammation Response Index in Small Cell Lung Cancer
2023 · Mehmet Uzun, Eda Çalışkan Yıldırım, et al. · Acta Oncologica Turcica · 6
PDF
Efficacy of everolimus plus hormonal treatment after cyclin-dependent kinase inhibitor; real-life experience, A TOG study
2024 · İsmail Beypınar, Hacer Demir, et al. · Breast Cancer Research and Treatment · 5
SUVmax-IPI as a New Prognostic Index in Metastatic Non-Small Cell Lung Cancer Patients Receiving Nivolumab
2025 · Nagihan Kolkıran, Atike Pınar Erdoğan, et al. · Current Oncology · 4
PDF
Novel tumor marker index combining carcinoembryonic antigen and carbohydrate antigen 19-9: New prognostic factor for metastatic colorectal cancer
2025 · Yusuf Ilhan, Onur Yazdan Balcik, et al. · World Journal of Gastrointestinal Oncology · 4
PDF
Geriatric nutritional risk index and controller nutritional status score before metastatic first-line chemotherapy predict survival in patients over 70 years of age with metastatic bladder cancer
2024 · Onur Yazdan Balçık, Bilgin Demir, et al. · Frontiers in Medicine · 4
Clinical Importance of the Hemoglobin, Albumin, Lymphocyte, Platelet Score in Metastatic Pancreatic Cancer
2023 · Onur Yazdan Balçık, Ali Aytaç, et al. · Acta Oncologica Turcica · 4
PDF
Mauriac Syndrome: Case Report and Review of the Literature
2017 · Ömercan TOPALOĞLU, Sibel DEMİRAL SEZER, et al. · Endocrinology research and practice. · 4
PDF
Pretreatment Lactate Dehydrogenase-to-Albumin Ratio and Clinical Outcomes in Extensive-Stage Small Cell Lung Cancer: A Multicenter Real-World Study
2026 · Ahmet Unlu, Asim Armagan Aydin, et al. · Journal of Clinical Medicine · 3
PDF
Real‐world effectiveness and safety of sacituzumab govitecan in patients with metastatic or unresectable locally advanced triple‐negative breast cancer: A multicenter study by the Turkish Oncology Group
2025 · Salih Tunbekici, Gokhan Sahin, et al. · International Journal of Cancer · 3
Incidence And Etiology Of Anemia In The Hospitalized Geriatric Patients
2013 · Sibel Demiral Sezer, Bilgin Demir, et al. · The Anatolian Journal of General Medical Research · 3
PDF
Outcomes of First-Line PARP Inhibitor Therapy in Ovarian Cancer: A Multicenter Retrospective Analysis
2026 · Baris Koksal, Hasan Cagri Yildirim, et al. · Journal of Clinical Medicine · 2
PDF
Real-world comparison of doxorubicin–ifosfamide versus gemcitabine–docetaxel regimens in metastatic uterine leiomyosarcoma: a multicenter retrospective study
2025 · Salih Tunbekici, Gokhan Sahin, et al. · Discover Oncology · 2
PDF
Neoadjuvant Regimens and Their Impact on Adjuvant T-DM1 Outcomes in HER2-Positive Early Breast Cancer
2025 · Ahmet Burak Agaoglu, Atike Pinar Erdogan, et al. · Medicina · 2
PDF
The efficacy of HDDPiW-jSB solution on docetaxel-induced alopecia of rats
2024 · Bilgin Demir, Buket Demirci, et al. · Cutaneous and Ocular Toxicology · 2
PDF
Prognostic significance of PNI, SIRI and LIPI in non small-cell lung cancer
2023 · Onur Yazdan BALÇIK, Ali AYTAÇ, et al. · Acta Medica Alanya · 2
PDF
Küçük hücreli akciğer kanserinde daha fazla kombine kemoterapi ile atezolizumab kullanımı sağkalımı uzatır mı?
2023 · Bilgin DEMİR, Ömer Faruk AKGÜL, et al. · Turkish Journal of Clinics and Laboratory · 2
PDF
Works count: 77
Citation count: 155
H-index: 7
I10-index: 2
Year
Topic
Type